PTG-200 - Protagonist Therapeutics, J&J
PTG-200: Data from P2 trial for Crohn's disease in H1 2021 (Stifel 2019 Healthcare Conference, Protagonist Therapeutics) Nov 21, 2019 
P2 data
http://wsw.com/webcast/stifel18/ptgx/
 
Nov 21, 2019
 
 
113ad6ff-1c0c-4009-b38b-6b1d9e42fdec.jpg